nantradol has been researched along with quinelorane in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarkson, FA; Howlett, AC; Madras, BK; Mathews, PJ; Meschler, JP | 1 |
| Conley, TJ; Howlett, AC; Meschler, JP | 1 |
2 other study(ies) available for nantradol and quinelorane
| Article | Year |
|---|---|
D(2), but not D(1) dopamine receptor agonists potentiate cannabinoid-induced sedation in nonhuman primates.
Topics: Animals; Cannabinoids; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Synergism; Hypnotics and Sedatives; Macaca fascicularis; Male; Motor Activity; Phenanthridines; Quinolines; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2000 |
Cannabinoid and dopamine interaction in rodent brain: effects on locomotor activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesics; Animals; Cannabinoids; Cyclohexanols; Dopamine Agonists; Immobilization; Male; Mice; Mice, Inbred ICR; Motor Activity; Phenanthridines; Quinolines | 2000 |